On March 27, 2023, the Company entered into a note purchase agreement, or the 'Note Purchase Agreement,' with RTW Investments LP and certain of its affiliates, or collectively, 'RTW.'
Under the License Agreement, the Company granted Corxel exclusive development and commercialization rights to any pharmaceutical product that uses a device to deliver etripamil by nasal spray
On May 15, 2021, the Company entered into a license and collaboration agreement, or the License Agreement, with Corxel, which is an entity affiliated with RTW Investments, LP, or “RTW,” an existing s…
Milestone Pharmaceuticals Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MIST-DEBT-10991
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
MIST-DEBT-10990
Warrants outstanding: 0.01
90%
xbrl warrant detail from xbrl 2022-12-31.
MIST-DEBT
Debt stack $58.4M
90%
Market cache reports total debt of $58.4M.
Milestone Pharmaceuticals Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Milestone Pharmaceuticals Inc..
Milestone Pharmaceuticals Inc. Ownership
Holder
Name
Confidence
Evidence
MIST-OWNER-RTW-INVESTMENTS-LP
RTW INVESTMENTS, LP
90%
13F overlay lists RTW INVESTMENTS, LP as top holder; 86 tracked holders.
Milestone Pharmaceuticals Inc. Extended Supply Chain Network
